It is possible that these cells replace cytotoxic lymphocytes in response to anti-PD-13,7 under immunosuppression conditions, increasing their tumor recruitment in tumors treated with anti-PD-1, as suggested here. The gene discussed is PDCD1; the disease is neoplasm.